NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotechnology’

15 August 2014

Biotech sector suffers from PE investment slump, weakens for third monthp

biotech Private equity and venture capital investment in the biotechnology sector has weakened for the third successive month due to a dearth of dealmaking, new research suggests.

7 August 2014

Venture capital-backed Juno Therapeutics raises $134m Series B

cancer juno Venture capital-backed biotechnology startup Juno Therapeutics has raised $134m in its Series B round to fund the development of its immunotherapies for cancer.

5 August 2014

Sofinnova-backed Auris cuts IPO price

auris Venture capital-backed Swiss biotechnology company Auris medical has significantly reduced the price of its upcoming IPO.

14 July 2014

Sofinnova Ventures could raise $500m for Fund IX

biotech virus lab Biotechnology-focused Sofinnova Ventures is targeting up to $500m for a ninth fund AltAssets reported it had started to raise earlier this month.

11 July 2014

TPG Capital life sciences arm launches first fund since 2008p

biomed_lrg The life sciences venture investment arm of TPG Capital has launched its fourth fundraise six years after hitting the market for its last vehicle.

8 July 2014

Great Point backs temp-controlled package business Softbox through growth recap

Softbox Healthcare-focused investment firm Great Point Partners has made a growth recapitalisation of UK temperature-controlled packaging business Softbox.

3 June 2014

SV Life Sciences brings in trio of venture partners for biotech investment team

microscope7_sq Specialist venture capital firm SV Life Sciences has hired a trio of new venture partners for its biotechnology investment team.

27 May 2014

Tao Invest leads Twist Bioscience’s $26m Series B

twist San Francisco-based synthetic DNA producer Twist Bioscience has secured $26m in a Series B round led by Tao Invest.

22 May 2014

Sofinnova leads €16.5m VC round in French biotech developer Lysogene

Gene therapy biotechnology company Lysogene has closed a €16.5m Series A financing led by French venture capital firm Sofinnova Partners.

13 May 2014

Private equity, venture investment in biotech surges following two slow months

biotech_lrg Private equity, venture capital and development capital investment activity in biotechnology companies rose sharply in April after two relatively poor months, a new report shows.

Page 1 of 812345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014